Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. [electronic resource]
Producer: 20080327Description: 224-9 p. digitalISSN:- 1078-0432
- Administration, Intravesical
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- BCG Vaccine -- administration & dosage
- Carcinoma, Transitional Cell -- pathology
- Female
- Fenretinide -- therapeutic use
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- prevention & control
- Placebos
- Survival Analysis
- Urinary Bladder Neoplasms -- pathology
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.